CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.

L265P

CIViC ID: 424 · Gene: MYD88

Variant Summary

Also known as
LEU265PRO,L273P,LEU273PRO,RS387907272
HGVS
NC_000003.11:g.38182641T>C,NP_002459.2:p.L265P,NM_002468.4:c.794T>C,ENST00000396334.3:c.794T>C
Variant Type(s)
missense_variant,gain_of_function_variant
Evidence Items
3

Evidence Level Distribution

Level B: 2Level D: 1

Evidence Items

Showing CIViC evidence rows where gene = MYD88 and variant = L265P.

LevelTypeDirectionSignificanceDiseaseDrugsRating
BPredictiveSupportsSensitivity/ResponseLymphoplasmacytic LymphomaIbrutinib4
BPrognosticSupportsBetter OutcomeChronic Lymphocytic Leukemia2
DPredictiveSupportsSensitivity/ResponseLymphoplasmacytic LymphomaIMG-2005-5,IRAK-1/4 Inhibitor1